Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001213900-25-105184
Filing Date
2025-11-03
Accepted
2025-11-03 16:03:20
Documents
3

Document Format Files

Seq Description Document Type Size
1 PROXY STATEMENT ea0261240-04.htm DEFA14A 35873
2 GRAPHIC tproxy_001.jpg GRAPHIC 1527902
3 GRAPHIC tproxy_002.jpg GRAPHIC 807855
  Complete submission text file 0001213900-25-105184.txt   3254822
Mailing Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431
Business Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431 561-961-1900
TherapeuticsMD, Inc. (Filer) CIK: 0000025743 (see all company filings)

EIN.: 870233535 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-00100 | Film No.: 251443992
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)